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Abstract 
The pack-years formula is a widely used estimate of lifetime tobacco smoking exposure, and 
greater pack-years have been associated with greater risk of chronic pain development and 
poorer pain-related outcomes among smokers with chronic pain. The pathophysiology 
underlying these associations is poorly understood. Regular tobacco smoking exposure may 
dysregulate homeostatic pain processes, producing an allostatic state of pain facilitation. 
Maladaptive pain mechanisms, such as central and peripheral sensitization, are chronic pain risk 
factors. Yet, no published research has involved a determination of the relation between lifetime-
smoking exposure and dysregulated pain processing. The current study used hierarchical linear 
regression analyses to test pack-years of tobacco smoking as a predictor of (1) spontaneous pain 
reporting (current pain severity, pain frequency in the last 180 days) among a sample of 228 
daily smokers without chronic pain, and (2) experimental capsaicin-induced pain reactivity (pain 
intensity, area of flare, mechanical pain sensitivity, and area of mechanical hyperalgesia) among 
101 daily smokers without chronic pain. Gender and alcohol-related factors (consumption and 
dependence) were explored as statistical moderators. As hypothesized, results indicated that 
pack-years smoking was positively and significantly associated with spontaneous current pain 
severity, past 180-day pain frequency, experimental pain intensity, mechanical pain sensitivity 
ratings, and area of mechanical hyperalgesia. Pack-years smoking was not significantly 
associated with neurogenic flare. Moderation analyses produced null results. These findings 
implicate central sensitization, but not peripheral sensitization, as a potentially relevant factor 
that may underlie the association between chronic tobacco smoking and increased risk for 
persistent pain development.
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Pack-Years of Tobacco Cigarette Smoking as a Predictor of Pain Reporting and Reactivity 
Tobacco dependence and pain are both highly prevalent and co-occurring conditions, 
with a combined annual economic burden in excess of $800 billion in the United States alone 
(CDC, 2014; Gaskin & Richard, 2012; IOM, 2011; Tsang et al., 2008). Pain is a 
multidimensional, subjective experience that consists of sensory-physiological, motivational-
affective, and cognitive-evaluative components (McMahon, Koltzenburg, Tracey, & Turk, 
2013). Smoking prevalence among individuals with co-occurring pain (e.g., 42-68%; Michna et 
al., 2004; Zvolensky, McMillan, Gonzalez, & Asmundson, 2009) may be greater than twice the 
rate observed in the general population (e.g., 15%; Jamal et al., 2016). Thus, interrelations 
between pain and tobacco cigarette smoking are of increasing interest to researchers and 
clinicians.  
Bidirectional models have posited that these conditions interact reciprocally, resulting in 
greater pain and the maintenance of tobacco dependence (Ditre, Brandon, Zale, & Meagher, 
2011; Zale, Maisto, & Ditre, 2016). Although nicotine has been shown to reduce pain in the 
short-term (e.g., Ditre, Heckman, Zale, Kosiba, & Maisto, 2016), long-term smoking has been 
implicated in the onset and progression of several chronically painful conditions (Shiri & Falah-
Hassani, 2016; Shiri, Karppinen, Leino-Arjas, Solovieva, & Viikari-Juntura, 2010; Sugiyama et 
al., 2010). Despite these known associations, research has yet to specify how regular tobacco use 
can engender pathological pain states.  
A recently proposed allostatic load model of addiction and pain may account for how 
chronic substance use can lead to pain development (Egli, Koob, & Edwards, 2012). Allostatic 
load models attempt to describe homeostatic dysregulation that results in persistent aberrant 
states, and have been used to account for phenomena observed in disorders related to addiction, 
stress, and emotion (Koob & Le Moal, 2001). In particular, the allostatic load model specific to 
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addiction and pain (see Figure 1) posits that repeated opponent process cycles of substance-
induced analgesia and withdrawal-induced hyperalgesia may dysregulate overlapping neural 
substrates to produce an imbalanced state of pain facilitation (Egli et al., 2012; Koob & Le Moal, 
1997; Koob & Le Moal, 2001). From this perspective, it could be hypothesized that chronic 
smoking (along with commensurate tobacco use/disuse cycles) dysregulates homeostatic pain 
mechanisms (i.e., endogenous pain facilitation/inhibition) to engender an allostatic state that 
over-facilitates nociception. Consistent with this perspective, experimental research has reliably 
demonstrated acute pain-inhibitory effects of nicotine administration (Ditre et al., 2016; Jackson 
& Damaj, 2013), and pain-facilitating effects of acute nicotine deprivation (Damaj, Kao, & 
Martin, 2003; Ditre, Zale, Kosiba, De Vita, & LaRowe, 2017; Grabus et al., 2005; Jackson, 
McIntosh, Brunzell, Sanjakdar, & Damaj, 2009). Yet, no published research has examined the 
relation between lifetime-smoking exposure and dysregulated pain processing.  
The associations between chronic smoking and pain reporting have been studied for 
nearly three decades (e.g., Deyo & Bass, 1989), with more recent research implicating pack-
years smoking as a unique risk factor in the development of persistent pain (Shiri & Falah-
Hassani, 2016; Shiri et al., 2010; Sugiyama et al., 2010). The pack-years formula is a widely 
used estimate of lifetime smoking exposure that is calculated by multiplying the number of 
cigarette packs smoked per day by the number of years smoking (Bernaards, Twisk, Snel, Van 
Mechelen, & Kemper, 2001). Greater pack-years have been associated with increased pain 
intensity, frequency, and duration among smokers seeking treatment for chronic pain (Scott, 
Goldberg, Mayo, Stock, & Poitras, 1999). Epidemiological studies have indicated that the risk 
for developing persistent pain increases as a function of greater pack-years (Deyo & Bass, 1989; 
Dubé et al., 2015; Mikkonen et al., 2008; Pisinger et al., 2011; Scott et al., 1999; Sugiyama et al., 
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2010). These data are consistent with the notion that lifetime smoking exposure may dysregulate 
pain processes, and promote the transition from acute to chronic pain (i.e., pain that extends 
beyond the expected period of healing; Turk & Okifuji, 2001). However, these findings do not 
address the pathophysiology underlying the transition to chronic pain in smokers. No research 
has been reported that tests the associations between pack-years smoking and either current 
spontaneous pain reporting or experimental pain reactivity among smokers without chronic pain.  
Addressing this research gap would have important clinical implications. To inform 
intervention design, researchers have emphasized the importance of identifying dysregulated 
pain processes that increase the risk for persistent pain development (McGreevy, Bottros, & 
Raja, 2011). Abnormal patterns of pain processing vary across clinical syndromes. This 
variability reflects differing underlying mechanisms that may yield insights about the 
pathophysiology, diagnosis, and treatment of clinical conditions (Lautenbacher & Fillingim, 
2004). Despite empirical evidence suggesting that smoking causes pain (e.g., Shiri et al., 2010), 
the pathophysiological mechanisms underlying this relation are poorly understood. Once 
identified, clinical researchers could examine the extent to which these neuroplastic mechanisms 
can be modified using behavioral and pharmacological interventions (McGreevy et al., 2011). 
Although additional research is needed to address these empirical gaps, current spontaneous pain 
reporting and experimental pain reactivity represent two complementary pain assessment 
methods that could inform our understanding of how chronic tobacco exposure may influence 
pain development.  
Current spontaneous pain reporting can be readily assessed by asking smokers to rate the 
severity of pain they are experiencing right now (e.g., using numerical rating scales of current 
pain intensity), and to indicate the frequency with which they experience pain (e.g., number of 
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days with pain). Although greater current pain reporting can reflect dysregulated pain processing, 
it does not provide information regarding pathophysiological mechanisms of action (Arendt-
Nielsen & Lautenbacher, 2004). Measuring psychophysiological reactivity to experimental pain 
induction, on the other hand, can yield insights into underlying mechanisms using a variety of 
laboratory methods (Arendt-Nielsen & Yarnitsky, 2009), including the current gold-standard 
approach of quantitative sensory testing (QST). 
The term quantitative sensory testing represents the evaluation of perceptual responses to 
the systematic application of quantifiable sensory stimuli (Boivie, 2003; Cruz-Almeida & 
Fillingim, 2014; Hansson, Backonja, & Bouhassira, 2007; Olesen, van Goor, Bouwense, Wilder-
Smith, & Drewes, 2012). Unlike self-reported pain ratings, QST employs highly standardized 
psychophysiological protocols to assess nervous system processes that underlie the experience of 
pain. QST evaluates both central and peripheral nervous system mechanisms using laboratory 
models that mimic painful conditions without causing lasting tissue damage (Edens & Gil, 
1995). The capsaicin QST model induces prolonged nociception that approximates spontaneous 
burning pain associated with neuropathic and inflammatory clinical pain states (Arendt-Nielsen 
& Andersen, 2005; Benarroch & Low, 1991; Hsieh & Lin, 1999; Parkhouse & Le Quesne, 
1988). In addition to experimental pain intensity ratings, this approach permits tests of 
neurogenic flare and mechanical hyperalgesia, which reflect peripheral and central sensitization, 
respectively (LaMotte, Lundberg, & Torebjork, 1992; Simone & Ochoa, 1991; Torebjork, 
Lundberg, & LaMotte, 1992). Given that peripheral and central sensitization are considered 
maladaptive neuroplastic mechanisms in the transition from acute to persistent pain (McGreevy 
et al., 2011), it is important to examine these processes among smokers who have not yet 
developed chronic pain. 
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Experimental pain intensity ratings provide a general measure of pain reactivity that 
involves peripheral conduction via afferent pain neurons (Schaible, 2006), and nociceptive 
processing in the central nervous system (Coghill, Sang, Maisog, & Iadarola, 1999). Neurogenic 
flare is considered a measure of peripheral sensitization (Klede, Handwerker, & Schmelz, 2003), 
in that it reflects visible neuropeptide-induced vasodilation caused by peripheral C-fiber 
activation (Brain & Grant, 2004; Geber et al., 2007; Holzer, 1998; Schmelz, 2009). Mechanical 
hyperalgesia is considered a measure of central sensitization (Klede et al., 2003) in that it reflects 
enhanced excitability of spinal dorsal horn neurons (Treede, Handwerker, Baumgärtner, Meyer, 
& Magerl, 2004), and the release of several pain-related neurotransmitters (i.e., glutamate, 
substance P, CGRP, somatostatin, and nitric oxide) at the central level (Sandkühler, 2009; Serra, 
Campero, & Ochoa, 1998; Ziegler, Magerl, Meyer, & Treede, 1999). 
An important next step in this line of research is to assess the extent to which pack-years 
smoking may be associated with increased current spontaneous pain reporting and experimental 
pain reactivity among smokers who have not yet developed chronic pain. Therefore, the current 
study had two primary aims. Aim 1 was to test pack-years of tobacco cigarette smoking as a 
predictor of spontaneous current pain severity and past 180-day pain frequency among daily 
smokers without chronic pain. Specifically, it was hypothesized that greater pack-years would 
predict greater current pain severity and greater frequency of pain during the last 180 days. Aim 
2 was to test whether pack-years smoking would predict experimental pain reactivity outcomes 
(i.e., pain intensity, neurogenic flare, and mechanical hyperalgesia) among a sample of daily 
cigarette smokers who do not have chronic pain. For the second aim, it was hypothesized that 
greater pack-years would predict greater experimental pain intensity ratings, larger area of 
neurogenic flare, greater mechanical pain sensitivity, and larger area of mechanical hyperalgesia. 
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As an exploratory aim, the current study also examined gender and alcohol-related factors as 
potential moderators of the relations hypothesized in Aims 1 and 2. Smokers are more likely to 
be male (CDC, 2015), and there is evidence that females are more sensitive to experimentally 
induced pain (Granot et al., 2008; Racine et al., 2010; Wise, Price, Myers, Heft, & Robinson, 
2002). Furthermore, researchers have hypothesized that chronic episodes of alcohol intoxication 
and withdrawal may produce an allostatic pain state, and alcohol dependence has been associated 
with greater allostatic load and dysregulated pain processing (Egli et al., 2012). The allostatic 
load generated from co-occurring alcohol and tobacco use may be greater than the dysregulation 
caused by either drug alone. Accordingly, the effects hypothesized in Aims 1 and 2 may be more 
evident among smokers who reported greater quantities and frequencies of alcohol consumption, 
as well as those who endorsed greater levels of alcohol dependence.  
Method 
Participants 
Participants were recruited from the community to participate in a larger, two-session 
experimental study that tested the effects of nicotine deprivation using a capsaicin pain model 
(Ditre et al., 2017). Respondents were screened by phone for the following inclusion criteria: (1) 
between 18-65 years of age; (2) currently smoking ≥ 15 cigarettes per day; and (3) ability to 
speak and read English. Respondents were excluded if they endorsed: (1) a current attempt to 
reduce or quit smoking; (2) current chronic pain; (3) current use of prescription pain 
medications; or (4) pepper allergy (contraindicated for capsaicin pain induction). Participants 
attended a baseline assessment and were subsequently randomized to one of three experimental 
conditions: continued smoking (N = 66), minimal 2-hour deprivation (N = 35), or extended 12-24 
hour deprivation (N = 127).   
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The parent study included a minimal deprivation group to ensure that continued smokers 
were not experiencing acute analgesic effects of nicotine. As expected, the primary study 
revealed no differences between the continued smoking and minimal deprivation groups on 
measures of cigarette craving, nicotine withdrawal, or current pain intensity prior to the 
experimental pain induction (Ditre et al., 2017). Findings from the parent study indicated that 
extended nicotine-deprivation significantly increased all measures of pain reactivity (Ditre et al., 
2017). These observed effects would likely confound analyses aiming to examine associations 
between pack-years smoking and pain reactivity among daily smokers. That is, a deprivation-
induced increase in pain reactivity represents an altered state that is likely different from how a 
participant might typically present under usual conditions. Given that current spontaneous pain 
reporting was assessed at the baseline session of the larger study (i.e., prior to randomization to 
deprivation condition), Aim 1 analyses included the entire sample (N = 228). To examine pain 
reactivity as a function of lifetime smoking exposure, Aim 2 analyses excluded participants who 
were randomly assigned to the extended nicotine deprivation condition to avoid the confounds 
described above. Thus, Aim 2 analyses included N = 101 participants who were randomized to 
either continued smoking (n = 66) or minimal deprivation conditions (n = 35).  
Measures 
Baseline assessment. 
Demographic questionnaire. Participants reported demographic information, including 
age, gender, race, ethnicity, education, employment status, and annual income.  
Smoking questionnaire. A smoking questionnaire assessed smoking history and current 
smoking status. Pack-years smoking was determined using two items where participants were 
asked, “For how many years, altogether, have you been a regular/daily smoker?” and “Since you 
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started regular/daily smoking, what is the average number of cigarettes you smoke per day?” 
Consistent with previous research, pack-years was computed as: (
cigarettes per day
20
)  ×
 years smoking (Deyo & Bass, 1989; Dubé et al., 2015; Mikkonen et al., 2008; Pisinger et al., 
2011; Scott et al., 1999; Sugiyama et al., 2010). In previous research, the pack-years calculation 
has demonstrated high test-retest reliability (ICC = .76; Brigham et al., 2009), and moderate to 
good relative validity when compared to prospective tobacco use estimates (κ = 0.79; Bernaards 
et al., 2001) 
Alcohol Consumption. The Alcohol Use Disorder Identification Test (AUDIT; Babor, 
Higgins-Biddle, Saunders, & Monteiro, 2001; Saunders, Aasland, Babor, De la Fuente, & Grant, 
1993) is a 10-item instrument that assesses current (defined in this study as the last 12 months) 
risk for alcohol abuse. The AUDIT has been shown to be a reliable and valid screening measure 
for possible hazardous or harmful alcohol consumption in adults. Items on this measure are 
summed to produce an overall score, with a total of 8 or more suggesting hazardous use and 
possible alcohol dependence. Furthermore, the AUDIT assesses three sub-domains of alcohol 
consumption, alcohol-related consequences, and symptoms of alcohol dependence, respectively 
(Reinert & Allen, 2002). Due to the aforementioned associations between alcohol-related factors, 
allostatic load, and dysregulated pain processing reported in the literature (Egli et al., 2012), we 
were primarily interested in testing the constructs of alcohol consumption (items 1-3) and 
dependence (items 8-10) as potential moderators of the effects hypothesized in Aims 1 and 2. 
Given our theoretical basis, we suspected that any detected alcohol-related interactions would 
most likely pertain to the consumption subscale, as it is comprised of items that assess quantity 
and frequency of alcohol use (Babor et al., 2001).  
Aim 1 pain reporting outcomes. 
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Current spontaneous pain severity and frequency of pain. A single item from the 
Graded Chronic Pain Scale (GCPS; Von Korff, 2011) assessed current pain severity. Participants 
responded to the question “How would you rate your pain RIGHT NOW?” using a numerical 
rating scale that ranged from 0 (no pain) to 10 (pain as bad as it could be). Pain frequency in the 
last 180 days was assessed with another item that asked, “On how many days in the last 180 days 
(6 months) have you had pain?” (Von Korff, 2011). 
Aim 2 experimental pain reactivity outcomes. 
Experimental pain intensity. Capsaicin-induced pain intensity was assessed using a 
visual analogue scale (VAS) that ranged from 0 (no pain) to 10 (pain as bad as you can imagine). 
The VAS has shown strong reliability and internal consistency in previous research (Price, Bush, 
Long, & Harkins, 1994). Participants provided ratings at five-minute intervals throughout the 
capsaicin application period. Consistent with the data analytic approach in the primary study, 
total pain ratings were obtained by calculating the area under the VAS curves (AUC) for each 
participant using the trapezoidal method (Matthews, Altman, Campbell, & Royston, 1990). The 
AUC calculation provides a summary measure that integrates serial pain assessments over the 
duration of the capsaicin procedure (Lee, Lee, Wu, Lee, & Chen, 2005). Thus, the AUC consists 
of information from all available data points, whereas less optimal measures, such as peak pain 
intensity, are quantified using only a portion of the data and may be less valid representations of 
sequential pain ratings. 
Neurogenic flare. Neurogenic flare was quantified as the area of visible skin 
inflammation (i.e., redness extending beyond the capsaicin application site; Helme & McKernan, 
1985). Consistent with previous work, the flare boundary was traced onto transparent acetate and 
scanned to generate an area value in pixels (Helme & McKernan, 1985). The pixels were 
subsequently converted into squared centimeters (cm2) for analysis.  
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Mechanical hyperalgesia. Mechanical hyperalgesia (i.e., increased sensitivity to 
mechanical stimulation) was assessed using a 6.65 von Frey hair (Bell-Krotoski & Tomancik, 
1987; Bell-Krotoski, Fess, Figarola, & Hiltz, 1995). A standardized 300 grams of force was 
applied at points separated by 1 centimeter (cm) along 8 linear paths radiating from the center of 
the application site to form 8 concentric von Frey rings (Modir & Wallace, 2010). Participants 
rated pain intensity at each point using a numerical rating scale ranging from 0 (no pain) to 10 
(pain as bad as you can imagine). Two distinct measures of mechanical hyperalgesia were 
quantified. First, pain sensitivity to mechanical stimulation was estimated by calculating the 
AUC for each von Frey ring. Second, the area of mechanical hyperalgesia was computed by 
entering the boundaries of hyperalgesia (defined as the last 50% reduction in pain ratings along 
each von Frey path) into an established vector algorithm (Gottrup et al., 2004; Werner, Petersen, 
Rowbotham, & Dahl, 2013).  
Procedure 
Participants were recruited to participate in the parent study using internet and newspaper 
advertisements (Ditre et al., 2017). Eligible daily tobacco smokers attended a baseline 
assessment session, where they provided informed consent, verified smoking status via exhaled 
carbon monoxide (CO ≥ 8ppm), completed measures of smoking history, spontaneous current 
pain reporting (Aim 1 outcomes), and other relevant variables (e.g., sociodemographic info). 
Participants were then randomized to 1 of the 3 experimental conditions, scheduled for an 
experimental session, and compensated $20. At the experimental session, participants completed 
pre-application measures, underwent a capsaicin QST pain reactivity assessment (Aim 2 
outcomes), and completed post-application measures. Participants were then debriefed and 
compensated $80. Procedural details are shown in Figure 2. 
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Experimental pain induction. Experimental pain was induced using capsaicin, a 
vanilloid receptor agonist derived from chili peppers (Arendt-Nielsen & Andersen, 2005). A 
10% capsaicin solution was applied to the non-dominant volar forearm via a 1.5cm x 1.5cm 
gauze pad (Baron et al., 1999). Capsaicin pain peaks in approximately 15-20 minutes (Geber et 
al., 2007; Petersen, Jones, Segredo, Dahl, & Rowbotham, 2001), and the substance was removed 
after 30 minutes.   
Data Analytic Strategy 
All statistical analyses were conducted using SPSS, version 21 (IBM, Armonk, New 
York). A series of bivariate correlations were performed to test zero-order associations among 
pack-years smoking, pain outcomes, sociodemographic factors, and AUDIT scores. Variables 
that were significantly associated with either the independent or dependent variables were 
considered for inclusion in subsequent analyses, as either covariates or potential moderators 
(Pocock, Assmann, Enos, & Kasten, 2002). Distributional assumptions were considered, and 
transformations (e.g., logarithmic, square root) were applied when indicated to improve data 
normality (Howell, 2012).  
The data-analytic strategy was hierarchical linear regression, and the enter method was 
used at each step. The enter method inputs all independent variables (predictors) simultaneously 
into the model. Enter is standard method of variable entry, unless theory sufficiently supports a 
different method. The extent to which the pack-years variable contributed to the prediction of the 
dependent variable was evaluated. The t test was used to determine the significance of each 
predictor, whereas change in R squared (∆R2) and squared semi-partial correlations (sr2) were 
used to assess the relative contribution of pack-years smoking to the observed variance in pain 
outcomes. 
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For Aim 1, separate hierarchical regression models were constructed to test each pain 
reporting outcome (current spontaneous pain severity, pain frequency in the last 180 days) 
among the entire sample (N = 228). Sociodemographic covariates were entered in the first step, 
and pack-years smoking was entered in the last step. For Aim 2 analyses, separate models tested 
each pain reactivity outcome (experimental pain intensity, area of flare, area of mechanical pain 
sensitivity ratings, and area of secondary hyperalgesia) among the non-deprived participants (N = 
101). Sociodemographic covariates were entered in the first step, and the second step included 
procedural factors that may have influenced pain reactivity outcomes (i.e., time since last 
cigarette, room temperature). Pack-years smoking was entered into the final step of the models.  
For the exploratory aims, gender and alcohol use (i.e., AUDIT consumption and 
dependence subscale scores) were tested as moderators of the associations between pack-years 
smoking and pain outcomes in both of the study samples. A significance level of p < .05 was 
used to determine if interaction terms were significant in the regression model. Moderation was 
tested using the PROCESS Macro for SPSS (Hayes, 2013). 
Results 
Aim 1: Pack-Years Smoking and Spontaneous Pain Reporting 
Participant characteristics. In Aim 1, participants included 228 current daily tobacco 
smokers (42.1% female; Mage = 41.5, SD = 12.4), who reported smoking approximately 21 
cigarettes per day (SD = 11) for an average of 24.4 years (SD = 12.3). The number of pack-years 
smoking for the sample ranged from 1.4 to 165, and had an average of 27.0 (SD = 23.2). The 
sample was predominately Caucasian (57.5%), and most participants had at least a high school 
education (76.8%). On average, participants reported experiencing pain on 44.2 days in the past 
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6 months. The sample yielded an average AUDIT score of 6.5 (SD = 7.7). Additional 
sociodemographic, pain, smoking, and drinking data are presented in Table 1. 
Bivariate correlations. The pack-years variable was log transformed to achieve a greater 
approximation of its distribution to normality before correlations and regressions were 
calculated. Pack-years smoking was positively correlated with current spontaneous pain severity 
(r = .22, p < .01), pain frequency in the last 180 days (r = .18, p < .01), and age (r = .69, p < 
.001). Pain severity was also correlated with alcohol dependence (r = .18, p < .01), whereas pain 
frequency was correlated with alcohol consumption (r = .23, p < .01). Given known associations 
between age, smoking exposure, and pain (e.g., Scott, 1999), all Aim 1 analyses were designed 
to control for age. Additional bivariate analyses are presented in Table 2. 
Pack-years smoking and current spontaneous pain severity. As seen in Table 3, 
results of the hierarchical regression analysis revealed that age did not account for a significant 
portion of the variance in current spontaneous pain severity ratings (Step 1: p = .62). However, 
as hypothesized, a positive and significant association between pack-years smoking and current 
pain severity was observed (Step 2: β = .30, p < .01). Examination of the ∆R2 statistic at Step 2 
revealed that pack-years accounted for approximately 5% of the unique variance in pain severity 
ratings.  
Pack-years smoking and frequency of pain in the last 180 days. Similar to the finding 
observed for current spontaneous pain severity, the results of separate hierarchical regression 
analyses indicated that pack-years smoking was positively and significantly associated with the 
frequency of pain in the last 180 days (Step 2: β = .30, p < .01), even after controlling for age 
(Table 4). As indicated by the ∆R2 value at Step 2, pack-years accounted for approximately 2% 
of the unique variance in reported pain frequency. 
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Aim 2: Pack-Years Smoking and Experimental Pain Reactivity 
Participant characteristics. In the Aim 2 sample, participants included 101 daily 
tobacco smokers, who reported smoking an average of 20.5 cigarettes per day (SD = 12.9) for 
approximately 24.8 years (SD = 12.4). The number of pack-years smoking for the sample in Aim 
2 ranged from 1.4 to 112.5, and averaged 26.9 (SD = 21.1). The sample was predominately male 
(59.4%) and Caucasian (50.5%). The sample yielded an average AUDIT score of 6.0 (SD = 6.7). 
Additional sociodemographic, smoking, and drinking data are presented in Table 5.  
Bivariate correlations. Before calculating correlations and regressions, square root 
transformations were applied to positively skewed area measurements of flare and mechanical 
hyperalgesia to improve normality. Log transformations were used to improve normality of 
mechanical pain sensitivity ratings for each of the von Frey rings. As presented in Table 6, pack-
years of tobacco cigarette smoking was positively correlated with age (r = .75, p < .001) and 
mechanical pain ratings at the outermost (8th) von Frey ring (r = .20, p < .05). Age was also 
negatively associated with area of flare (r = -.30, p < .01) and mechanical pain ratings at the 
innermost (1st) von Frey ring (r = -.21, p < .05). Race was positively associated with area of flare 
(r = .48, p < .001), and negatively associated with mechanical pain ratings at the outermost von 
Frey ring (r = -.31, p < .01) and time since last cigarette (r = -.20, p < .05). Gender was 
negatively correlated with mechanical pain ratings at the innermost (1st) von Frey ring. AUDIT 
consumption scores were negatively correlated with area of mechanical hyperalgesia (r = -.27, p 
< .01). Again, based on these observations, and known associations between age, smoking 
exposure, and pain (e.g., Scott, 1999), all Aim 2 analyses were designed to control for the 
influence of age. Furthermore, previous research has demonstrated that African Americans tend 
to show less hyperalgesia and neurogenic flare in response to the application of topical capsaicin, 
 
  
 15  
 
especially in comparison to Caucasian participants (Wang et al., 2010). Given that the current 
sample has a similar proportion of White and Non-White participants (47.5% African American), 
as well as the observed associations between race, flare, and mechanical pain sensitivity, race 
was entered as a covariate in all Aim 2 analyses.  
Experimental pain intensity ratings. As seen in Table 8, results of hierarchical 
regression analysis revealed that neither age nor race accounted for a significant portion of the 
variance in experimental pain intensity ratings at Step 1 (p = .52). Experimental factors added in 
Step 2 (i.e., time since last cigarette and room temperature) did not account for a significant 
portion of the variance in pain intensity ratings either (p = .57). At Step 3 however, as 
hypothesized, the analyses revealed a positive and significant association between pack-years 
smoking and experimental pain intensity ratings (β = .51, p < .01). Examination of the ∆R2 
statistic at Step 3 showed that pack-years smoking accounted for approximately 11% of the 
unique variance in pain intensity ratings.  
Neurogenic flare. As shown in Table 9, hierarchical regression analyses revealed that 
both age and race accounted for a significant portion of variance in area of flare measurements at 
Step 1 (p = .00). Whereas age (p = .00), race (p = .00), and room temperature (p = .02) 
accounted for a significant portion of variance in flare measurements at Step 2, time since last 
cigarette did not (p = .88). At Step 3 however, no association was observed between pack-years 
smoking and area of flare (p = .38).  
Mechanical pain sensitivity. As demonstrated in Table 10, Step 1 of the hierarchical 
regression model revealed that neither age nor race accounted for a significant portion of 
variance in the mechanical hyperalgesia area measurements (p = .32). Whereas age (p = .57), 
race (p = .12), and time since last cigarette (p = .39) were not significant at Step 2, room 
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temperature accounted for a significant portion of variance in mechanical hyperalgesia area 
measurements (p = .04). As hypothesized, Step 3 analyses revealed a positive and significant 
association between pack-years smoking and area of mechanical hyperalgesia, even after 
controlling for these relevant factors (Step 3: β = .30, p < .05). Examining the ∆R2 statistic at 
Step 3 revealed that pack-years of tobacco smoking accounted for approximately 4% of the 
unique variance in mechanical hyperalgesia area measurements. Also as hypothesized, separate 
hierarchical models revealed that pack-years smoking was positively and significantly associated 
with ratings of mechanical pain sensitivity at seven of the von Frey rings (p’s < .05), even after 
controlling for age, race, time since last cigarette, and room temperature. For these associations, 
the proportion of variance accounted for by pack-years smoking ranged from 4 - 8%. Table 7 
presents the results at Step 3 for mechanical pain sensitivity ratings at each von Frey ring.  
Exploratory Moderation Analyses 
Separate exploratory regression models were used to test gender and AUDIT subscale 
scores (i.e., consumption and dependence) as moderators of the association of pack-years 
smoking with outcomes in Aim 1 and 2. Analyses revealed no moderation effects of gender on 
any of the associations tested in either sample (p’s > .05). Similarly, neither of the AUDIT 
subscale scores was a significant moderator of the observed associations of pack-years on 
spontaneous pain reporting and experimental pain reactivity (p’s > .05). Coefficients for the 
exploratory moderation analyses are presented in Table 11.  
Discussion 
The current study is the first to investigate pack-years, an index of lifetime tobacco 
smoking exposure, as a predictor of spontaneous pain reporting (i.e., current pain severity and 
frequency) and experimental pain reactivity (i.e., pain intensity, neurogenic flare, and mechanical 
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hyperalgesia) among smokers without chronic pain. As hypothesized, pack-years smoking was 
observed to be positively and significantly associated with greater current spontaneous pain 
severity and frequency of pain in the past 180 days. These findings highlight the relevance of 
smoking and pain relations, even among those without chronic pain. Also as hypothesized, 
greater pack-years smoking was associated with greater capsaicin-induced pain intensity, 
heightened mechanical pain sensitivity, and larger areas of mechanical hyperalgesia. As such, 
this study provides evidence for an exposure-response relation between lifetime tobacco smoking 
exposure and dysregulated pain processes, primarily at the central level. Pack-years was not 
found to be significantly associated with neurogenic flare measurements, which provide an index 
of peripheral sensitization. Taken together, these data implicate central sensitization, but not 
peripheral sensitization, as a relevant factor to consider in the relation between chronic tobacco 
smoking and increased risk for persistent pain development. 
Nicotinic acetylcholine receptors (nAChRs) are widespread throughout the central 
nervous system, especially in regions associated with pain transmission, such as the spinal dorsal 
horn, locus coeruleus, and thalamus (Shi et al., 2010). Activation of these receptors results in the 
release of endogenous opioids and norepinephrine, which can reduce facilitatory pain pathways 
and enhance inhibitory pain pathways, resulting in reduced transmission of nociceptive input. 
That is, nicotine can confer analgesia by acting on nAChRs in the brain and spinal cord (Shi et 
al., 2010). An allostatic load model of substance use and pain (e.g., Egli, Koob, & Edwards, 
2012) would posit that repeated opponent process cycles of nicotine-induced analgesia and 
withdrawal-induced hyperalgesia would dysregulate these central mechanisms to engender a 
persistent imbalance that favors pain facilitation. Consistently, the current results provide 
evidence for enhanced facilitation of pain transmission at the central level as a function of 
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smoking chronicity. Associations between peripheral pain mechanisms and tobacco use are less 
understood due to a disproportionate focus on central processes in the extant literature. Although 
analyses for an index of peripheral processes (neurogenic flare) produced null findings in the 
current study, additional research would be needed before concluding that effects were 
exclusively central in nature.  
The results implicating the importance of central sensitization may be viewed in the 
context of other clinically relevant research findings. In this regard, there are data that suggest 
that central sensitization, a chronic pain-risk factor, can be modified using pharmacological and 
behavioral strategies. Pharmacological research has shown that NMDA antagonists (e.g., 
Ketamine) inhibit central sensitization (McGreevy et al., 2011). Additionally, a brief Cognitive 
Behavioral intervention for pain has been shown to significantly reduce secondary hyperalgesia 
(i.e., central sensitization) in healthy human subjects undergoing an experimental pain task 
(Salomons, Moayedi, Erpelding, & Davis, 2014). Although additional clinical research is 
needed, reducing central sensitization in chronic tobacco smokers may mitigate the risk of 
persistent pain development following an acute injury. Behavioral interventions that promote 
smoking cessation may also affect dysregulated pain processing in smokers. 
Despite stated concerns about difficulties smokers may have with short-term abstinence, 
researchers have proposed that recovery from the effects of chronic nicotine exposure may 
improve pain pathophysiology in the long-term (Shi et al., 2010). Though more research is 
needed, clinical attempts to treat the pathophysiological effects of chronic smoking on pain may 
potentially be enhanced in the context of prolonged smoking abstinence. If chronic smoking 
engenders an allostatic state of pain facilitation, then removing this potential cause may improve 
additional efforts to reduce maladaptive sensitization. Nonetheless, tobacco cessation alone may 
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not be enough to mitigate the effects of chronic smoking, which have been shown to produce 
persistent alterations in nervous system functioning that can endure long after cessation (Perkins 
et al., 2001). Combining smoking cessation interventions with targeted treatments for pain may 
have the benefit of improving outcomes for both (Ditre et al., 2011; Zale et al., 2016). Integrated 
treatments, such as Cognitive Behavioral Therapy protocols for pain and smoking cessation 
(Zale et al., 2016), and tailored nicotine replacement therapies that confer analgesic effects in 
smokers with pain (Ditre et al., 2016), have been proposed. Additionally, psychoeducation about 
smoking-health interactions has been shown to increase motivation to quit smoking (e.g., 
McCaul et al., 2006; Zvolensky, Lejuez, Kahler, & Brown, 2003). Guidelines for brief 
motivational substance-use interventions emphasize education about interactions between 
substance use and health-related conditions (SAMHSA, 2012).  
Although smokers with co-occurring pain may benefit from these types of tailored 
interventions (Ditre et al., 2011; Zale et al., 2014), the current study also has implications for 
smokers who have not yet developed pain. Providers may deliver brief psychoeducational 
interventions that inform patients about the interrelations between smoking and pain, including 
how smoking exposure is associated with increased pain sensitivity, dysregulated pain 
processing, and greater risk for chronic pain development. Further study of the 
pathophysiological mechanisms underlying the association between tobacco smoking and pain 
development could ultimately inform clinical research that aims to break the causal chain. 
None of the reported main effects were found to be moderated by gender or alcohol-
related variables. Null findings may be attributable to several factors. Moderation analyses may 
have had limited statistical power, particularly in the reduced Aim 2 sample (N = 101). The sizes 
of the main effects detected in this study were relatively small, and the regression models 
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explained a modest proportion of variance in the tested outcomes. Moderation effect sizes may 
be even smaller, which could have further reduced power to detect interactions (Collins et al., 
2009). In addition, despite known sex/gender differences on certain measures of experimental 
pain reactivity (e.g., threshold and tolerance), most research has shown no such differences on 
measures of pain intensity, even when using varying models of experimental pain (Racine et al., 
2012). In exploratory analyses, alcohol consumption and dependence were tested as moderators, 
because it was thought that allostatic load might have been greater among those with a history of 
heavy drinking and chronic tobacco smoking (Egli et al., 2012). Although the first three items of 
the AUDIT measure quantity and frequency of recent (defined as past year in this study) alcohol 
consumption, they do not quantify lifetime alcohol exposure. Future research may benefit from 
using instruments that specifically measure alcohol use patterns over the lifetime (e.g., 
Concordia Lifetime Drinking Questionnaire; Chaikelson, Arbuckle, Lapidus, & Gold, 1994). 
 Although not tested in this study, ethnic/racial differences may be a potential moderating 
factor that should be considered in future research. Ethnic/racial disparities in smoking-related 
factors have been reported in the literature (Sakuma et al. 2016; Caraballo, Yee, Gfroerer, & 
Mirza, 2008). Responses to experimentally induced pain have also been found to differ as a 
function of ethnicity/race (Rahim-Williams et al. 2012; Wang et al. 2010). Thus, future 
investigations would benefit from examining interaction effects between ethnicity/race, tobacco 
smoking exposure, and pain reactivity.  
The current study had several notable strengths. The recruitment of a relatively large 
community sample of daily tobacco smokers was beneficial, for both external validity and 
statistical power in the primary aims. By examining these associations in a sample without 
chronic pain, hypotheses about the transition to persistent pain in smokers may be advanced. 
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Employing sophisticated QST methods permitted various mechanistic insights that likely have 
implications for the study, prevention, diagnosis, and treatment of pain in tobacco smokers.  
Several limitations of the current study should also be considered in interpreting its 
findings. First, the retrospective pack-years calculation may be susceptible to recall errors 
(Bernaards et al., 2001; Brigham et al., 2009). The equation can generate a similar outcome for 
individuals with disparate smoking histories. For example, someone who smoked 10 cigarettes a 
day for 10 years would have the same number of pack-years as someone who smoked 20 
cigarettes for 5 years (i.e., 5 pack-years). It also does not account for quit attempts, periods of 
abstinence during the lifetime, or other forms of tobacco use (e.g., cigar smoking). Furthermore, 
any index of lifetime substance use will also be strongly associated with age, given that older 
adults will have had more time to expose themselves to substances compared to younger 
individuals. Despite these limitations, the pack-years calculation remains a commonly used 
method for estimating lifetime smoking exposure, which cannot be quantified by other tobacco 
use variables alone (e.g., cigarettes per day; Bernaards et al., 2001; Brigham et al., 2009). 
Second, the sample consisted primarily of daily tobacco smokers who reported smoking at least 
15 cigarettes per day. Although the relations under study may be more evident among daily 
tobacco smokers, future research should also examine these processes among lighter and 
intermittent smokers to enhance external validity. Former smokers should also be examined to 
determine the extent to which indicators of allostatic load have persisted or alleviated post-
cessation. Third, this was a cross-sectional, observational study, and therefore it is not possible to 
make inferences about the dynamics of relations among variables. Future research may benefit 
from the application of prospective designs that assess pain reactivity closer to the onset of 
smoking to examine pathophysiological changes over time. Fourth, experimental pain models, 
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such as the capsaicin paradigm used in this study, are merely analogs of clinical pain. 
Standardized pain induced in a laboratory differs from pain occurring in other contexts (e.g., 
clinical setting), which may limit the generalizability of outcomes associated with these models 
(Edens and Gil, 1995). Nonetheless, clinical pain often covaries with numerous confounding 
factors (e.g., depression), whereas experimental pain induction reduces threats to internal validity 
while providing useful measures of pain nervous system functioning (Olesen et al., 2012; Kumar 
Reddy et al. 2012). Fifth, although these data may provide insight into mechanisms of 
endogenous pain facilitation (i.e., peripheral and central sensitization) that have been implicated 
in the development of persistent pain, future research may also examine the effect of lifetime 
smoking exposure on endogenous pain inhibition (e.g., conditioned pain modulation) among 
smokers. Finally, many factors relevant to the study aims were not included in analyses because 
they were not measured in the parent study. For example, the parent study did not collect 
secondary traces of neurogenic flare, and analyses of inter-rater reliability for this outcome could 
not be conducted. Additionally, although alcohol use was assessed as a component of the 
AUDIT, use of additional substances was not measured. Future research should include a 
comprehensive assessment of current and past substance use, given that other drugs have been 
posited to affect allostatic load (e.g., Egli et al., 2012; Elman & Borsook, 2016).  
In conclusion, the current study provides preliminary evidence of dysregulated pain 
processing as a function of lifetime smoking exposure. Results suggest that central sensitization 
may be a possible mechanism underlying associations between tobacco smoking exposure and 
pain. Despite smoking being identified as a causal agent in chronic pain development, poor 
pathophysiological understanding of this association remains a critical barrier to successful pain 
prevention and treatment for this population (Shi et al. 2010). Indeed, the precise explication of 
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mechanisms underlying these associations will require extensive research. Given the results of 
the current study, future research that examines smoking-pain pathophysiology is warranted. 
Identifying dysregulated pain processes in regular smokers would allow clinical researchers to 
examine the extent to which these neuroplastic mechanisms can be modified using various 
interventions. 
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Table 1 
 
Aim 1 Sample Sociodemographic and Smoking Characteristics 
Participant Characteristics (N = 228) N % 
Gender   
Female 96 42.1 
Income   
<30K 169 74.1 
30-50K 27 11.9 
>50K 32 14.0 
Education   
Did not graduate high school 53 23.2 
High school or part college 134 58.7 
Technical school/Associates 27 12.0 
Four-year college or more 14 6.1 
Marital Status   
Single 138 60.5 
Married 36 15.8 
Divorced/Other 54 23.7 
Ethnicity   
Hispanic/Latino 9 3.9 
Not Hispanic/Latino 219 96.1 
Race   
Caucasian 131 57.5 
Black/African American 89 39.0 
Other 8 3.5 
 M SD 
Age 41.5 12.4 
Pack-Years Smoking 1 27.0 23.2 
Average Cigarettes Per Day 21.1 11.0 
Years of Regular Smoking 24.4 12.3 
AUDIT Total 2 6.5 7.7 
Consumption 3.2 3.2 
Dependence  1.3 2.8 
Problematic Use 2.0 3.3 
Note. 1 Pack-Years =  
𝑐𝑖𝑔𝑎𝑟𝑒𝑡𝑡𝑒𝑠 𝑝𝑒𝑟 𝑑𝑎𝑦
20
 × 𝑦𝑒𝑎𝑟𝑠 𝑠𝑚𝑜𝑘𝑖𝑛𝑔; 2 Alcohol Use 
Disorders Identification Test.  
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Table 2 
 
Bivariate Pearson Correlations Between Primary Variables of Interest 
Variable r 
 1 2 3 4 5 6 7 
1. Pack-Years Smoking - .22** .18** .69*** .03 -.05 -.01 
2. Pain Severity  - .53*** .10 .09 .05 .18** 
3. Pain Frequency   - .10 .08 .23** .10 
4. Age    - -.05 -.04 -.02 
5. Gender     - .19** .16* 
6. AUDIT Consumption 1      - .50*** 
7. AUDIT Dependence       - 
Note. N = 228. 1 Alcohol Use Disorders Identification Test. 
*p  < .05, ** p < .01, *** p < .001 
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Table 3      
      
Hierarchical Regression Model with Spontaneous Current Pain Severity Entered as 
the Criterion Variable 
 ∆R2 β t sr2 p 
Step 1 .01    .14 
Age  .10 1.48 .01 .62 
Step 2 .05    .00** 
Age  -.12 -1.21 .01 .23 
Pack-Years Smoking  .30 3.34 .05 .00** 
Note. N = 228. ∆R2= change in R2; β = standardized beta weights; sr2 = squared semi-
partial correlations; 
*p  < .05, ** p < .01, *** p < .001 
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Table 4      
      
Hierarchical Regression Model with Past 180-Day Pain Frequency Entered as the 
Criterion Variable 
 ∆R2 β t sr2 p 
Step 1 .01    .14 
Age  .10 1.53 .01 .13 
Step 2 .02    .00** 
Age  -.04 -.47 .00 .64 
Pack-Years Smoking  .21 2.30 .02 .02* 
Note. N = 228. ∆R2= change in R2; β = standardized beta weights; sr2 = squared semi-
partial correlations; 
*p  < .05, ** p < .01, *** p < .001 
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Table 5 
 
Aim 2 Sample Sociodemographic and Smoking Characteristics 
Participant Characteristics (N = 101) N % 
Gender   
Female 41 40.6 
Income   
<30K 81 80.2 
30-50K 10 9.8 
>50K 10 10.0 
Education   
Did not graduate high school 26 25.7 
High school or part college 59 58.4 
Technical school/Associates 9 8.9 
Four-year college or more 7 7.0 
Marital Status   
Single 65 64.4 
Married 13 12.9 
Divorced/Other 23 22.7 
Ethnicity   
Hispanic/Latino 5 5 
Not Hispanic/Latino 96 95 
Race   
Caucasian 51 50.5 
Black/African American 47 46.5 
Other 3 3.0 
 M SD 
Age 42.5 12.9 
Pack-Years Smoking 1 26.9 21.1 
Average Cigarettes Per Day 20.5 10.3 
Years of Regular Smoking 24.8 12.4 
AUDIT Total 2 6.0 6.7 
Consumption 3.0 2.9 
Dependence  1.2 2.4 
Problematic Use 1.9 2.8 
Note. 1 Pack-Years =  
𝑐𝑖𝑔𝑎𝑟𝑒𝑡𝑡𝑒𝑠 𝑝𝑒𝑟 𝑑𝑎𝑦
20
 × 𝑦𝑒𝑎𝑟𝑠 𝑠𝑚𝑜𝑘𝑖𝑛𝑔; 2 Alcohol Use 
Disorders Identification Test.  
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Table 6      
      
Bivariate Pearson Correlations Between Primary Variables of Interest   
Variable  r 
 1 2 3 4 5 6 7 8 9 10 11 12 13 
1. Pack-Years Smoking - .13 -.12 .05 .20* -.01 .75*** .10 .12 .09 -.13 -.16 .08 
2. AUC Pain Intensity  - .24* .46*** .29** .58*** -.11 -.03 -.05 .05 -.08 -.16 .13 
3. Area of Flare   - .02 -.17 .12 -.30** .48*** -.03 -.13 .30** -.04 -.13 
4. Mechanical Hyperalgesia Area    - .73*** .82*** -.06 -.14 -.09 .10 .18 -.27** .14 
5. von Frey Ring 8 (outermost)     - .51*** .15 -.31** -.04 .10 .14 -.11 .20* 
6. von Frey Ring 1 (innermost)      - -.21* -.05 -.20* .07 .21* -.19 .13 
7. Age       - -.05 .10 .18 -.13 -.06 .07 
8. Race        - .11 -.20* .18 -.05 -.13 
9. Gender 1         - .02 -.03 .25* .14 
10. Time Since Last Cigarette          - -.05 .09 .00 
11. Room Temperature (°F)           - -.08 -.18 
12. AUDIT Consumption 2             - .39*** 
13. AUDIT Dependence             - 
Note. N = 101. 1 Gender: 0 = female, 1 = male; 2 Alcohol Use Disorders Identification Test. 
*p  < .05, ** p < .01, *** p < .001 
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Table 7      
      
Hierarchical Regressions of Experimental Pain Reactivity Outcomes on Pack-Years 
Smoking  
 ∆R2 β t sr2 p 
AUC Pain Intensity .11 .51 3.47 .11 .00** 
Area of Flare .01 .11 0.88 .01 .38 
Area of Mechanical Hyperalgesia .04 .30 2.03 .04 .04* 
von Frey Ring 1  .08 .43 2.98 .08 .00** 
von Frey Ring 2 .07 .40 2.78 .07 .00** 
von Frey Ring 3 .07 .40 2.77 .07 .00** 
von Frey Ring 4 .06 .37 2.56 .06 .01* 
von Frey Ring 5 .05 .34 2.33 .05 .02* 
von Frey Ring 6 .02 .24 1.64 .02 .10 
von Frey Ring 7 .04 .30 2.10 .04 .04* 
von Frey Ring 8 .05 .33 2.35 .05 .02* 
Note. N = 101. These data reflect only Step 3 of the individual hierarchical 
regressions of Aim 2 experimental pain reactivity outcomes on pack-years smoking. 
Thus, all analyses presented have been adjusted for age, race, time since last 
cigarette, and room temperature; ∆R2= change in R2; β = standardized beta weights; 
sr2 = squared semi-partial correlations. 
*p  < .05, ** p < .01, *** p < .001 
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Table 8      
      
Hierarchical Regression Model with Experimental Pain Intensity Entered as the 
Criterion Variable 
 ∆R2 β t sr2 p 
Step 1 .01    .52 
Age  -.11 -1.10 .01 .28 
Race  -.04 -0.38 .00 .71 
Step 2 .01    .57 
Age  -.13 -1.28 .01 .21 
Race  -.01 -0.10 .00 .93 
Time Since Last Cig.  .07 0.63 .00 .53 
Room Temp (°F)  -.09 -0.86 .00 .39 
Step 3 .11    .00** 
Age  -.52 -3.49 .11 .00** 
Race  -.08 0.80 .00 .42 
Time Since Last Cig.  .08 0.79 .00 .43 
Room Temp (°F)  -.06 -0.06 .00 .57 
Pack-Years  .51 3.47 .11 .00** 
Note. N = 101. ∆R2= change in R2; β = standardized beta weights; sr2 = squared semi-
partial correlations. 
*p  < .05, ** p < .01, *** p < .001 
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Table 9      
      
Hierarchical Regression Model with Area of Flare Entered as the Criterion Variable 
 ∆R2 β t sr2 p 
Step 1 .30    .00*** 
Age  -.27 -3.23 .07 .00** 
Race  .46 -5.49 .21 .00*** 
Step 2 .04    .08 
Age  -.25 -2.97 .06 .00** 
Race  .43 5.04 .17 .00*** 
Time Since Last Cig.  .01 0.15 .00 .88 
Room Temp (°F)  .19 2.29 .04 .02* 
Step 3 .01    .38 
Age  -.34 -2.62 .05 .01* 
Race  .42 4.75 .16 .00*** 
Time Since Last Cig.  .02 0.18 .00 .86 
Room Temp (°F)  .20 2.36 .04 .02* 
Pack-Years  .11 0.88 .01 .38 
Note. N = 101. ∆R2= change in R2; β = standardized beta weights; sr2 = squared semi-
partial correlations. 
*p  < .05, ** p < .01, *** p < .001 
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Table 10      
      
Hierarchical Regression Model with Area of Mechanical Hyperalgesia Entered as the 
Criterion Variable 
 ∆R2 β t sr2 p 
Step 1 .02    .32 
Age  -.07 -0.67 .00 .50 
Race  -.14 -1.40 .02 .16 
Step 2 .05    .09 
Age  -.06 -0.58 .00 .57 
Race  -.16 -1.56 .02 .12 
Time Since Last Cig.  .09 0.86 .01 .39 
Room Temp (°F)  .21 2.07 .04 .04* 
Step 3 .04    .04* 
Age  -.29 -1.85 .03 .06 
Race  -.20 -1.91 .04 .05 
Time Since Last Cig.  .10 0.94 .01 .35 
Room Temp (°F)  .23 2.28 .05 .03* 
Pack-Years  .30 2.03 .04 .04* 
Note. N = 101. ∆R2= change in R2; β = standardized beta weights; sr2 = squared semi-
partial correlations. 
*p  < .05, ** p < .01, *** p < .001 
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Table 11 
 
Results from the Last Steps of  Exploratory Moderation Regressions 
 
Gender 
AUDIT: 
Consumption Score 
AUDIT: 
Dependence Score 
Criterion Variables b t b t b t 
Spontaneous Pain Reporting (Aim 1; N = 228)       
Current Pain Severity 0.20 0.26 -0.03 -0.36 0.02 0.13 
Past 180-Day Pain Frequency -3.61 -0.20 -0.89 -0.30 -1.52 -0.41 
Experimental Pain Reactivity (Aim 2; N = 101)       
AUC Pain Intensity -2.17 -0.64 1.70 0.37 1.40 0.11 
Area of Flare 1.19 1.27 0.03 0.23 0.32 1.30 
Mechanical Hyperalgesia Area 0.19 0.09 0.21 0.78 -0.60 -0.79 
Von Frey Ring 8 (Outermost) -0.12 -0.57 0.00 -0.16 -0.09 -1.17 
Von Frey Ring 1 (Innermost) -0.05 -0.14 0.03 0.86 -0.01 -0.06 
Note. 1 Alcohol Use Disorder Identification Test. No significant interaction effects were identified. 
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Figure 1. Illustration depicting the allostatic-load model of addiction proposed G. F. Koob and Le 
Moal (2001), an extension of the opponent-process model of motivation in addiction proposed by 
Solomon and Corbit (1974). Initial drug use produces hedonic effects (Process A); subsequent 
disuse leads to withdrawal-induced opponent effects (Process B), before returning to set-point at 
baseline. Chronic use/disuse cycles result in diminished hedonic effects (Process A’) and amplified 
opponent effects (Process B’) due to the suppression of the set-point by allostatic load. Eventually, 
chronic substance use leads to an enduring pathophysiological state. Allostatic load suppresses the 
set-point far below baseline, such that drug use serves to mitigate opponent effects instead of 
producing hedonic effects. This allostatic state reflects a chronic deviation of the homeostatic 
system from its normal function.  
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Baseline Session Smoking Manipulation Experimental Session 
Informed Consent 
CO Verification 
Baseline Measures 
Randomization 
12-24 hour Extended Deprivation 
2 hour Minimal Deprivation 
Continued Smoking 
Capsaicin 
Pain 
Induction 
Post-
Application 
Measures 
Figure 2. Experimental procedure in the parent study (Ditre et al., under review). 
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